Calgary Retina Consultants
Calgary, Alberta, Canada
Ophthalmologist in Calgary, Alberta
5340 1 St SW #200, Calgary, AB T2H 0C8
About Calgary Retina Consultants
"Ophthalmologists, Retina Specialists Referrals, please fax (403) 286-6819"
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
6
Allergan
1
IVERIC bio, Inc.
1
Novartis Pharmaceuticals
1
Unity Health Toronto
1
Clinical Trials at Calgary Retina Consultants
During the past decade, Calgary Retina Consultants conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 4 clinical trials were completed, i.e. on
average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME)
2010-07-01
2013-03-01
Completed
241
Intravitreal Aflibercept in Wet Age Related Macular Degeneration Patients With an Incomplete Response to Routine Ranibizumab Injections
2014-04-17
2017-02-21
Terminated
23
A Study Investigating the Efficacy and Safety of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
2014-09-18
2018-01-29
Terminated
906
Safety and Efficacy of Abicipar Pegol in Participants With Neovascular Age-related Macular Degeneration
2015-06-25
2019-06-06
Completed
949
A Study of Disease Progression in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
2015-06-24
2018-01-31
Terminated
296
A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema
2018-10-09
2021-08-27
Completed
951
A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (TENAYA)
2019-02-19
2022-01-18
Completed
671
A Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Diabetic Macular Edema
2020-08-05
2023-08-18
Active, not recruiting
1,479
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Calgary Retina Consultants" #1 sponsor was "Hoffmann-La Roche" with 6 trials, followed by "Allergan" with 1 trials
sponsored, "IVERIC bio, Inc." with 1 trials sponsored, "Novartis Pharmaceuticals" with 1 trials sponsored and "Unity Health Toronto"
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
Clinical Trials Conditions at Calgary Retina Consultants
According to Clinical.Site data, the most researched conditions in "Calgary Retina Consultants" are
"Diabetic Macular Edema" (3 trials), "Geographic Atrophy" (3 trials), "Macular Degeneration" (2 trials), "Age Related Macular Degeneration" (1 trials) and "Neovascular Age-related Macular Degeneration" (1 trials). Many other conditions were trialed in "Calgary Retina Consultants" in a lesser frequency.
Clinical Trials Intervention Types at Calgary Retina Consultants
Most popular intervention types in "Calgary Retina Consultants" are "Drug" (9 trials), "Other" (5 trials) and "Procedure" (3 trials). Other intervention types were less common.
The name of intervention was led by "Sham Procedure" (5 trials), "Faricimab" (4 trials), "Aflibercept" (3 trials), "Sham" (2 trials) and "Abicipar Pegol" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Calgary Retina Consultants
The vast majority of trials in "Calgary Retina Consultants" are
10 trials for "All" genders.
Clinical Trials Status at Calgary Retina Consultants
Currently, there are NaN active trials in "Calgary Retina Consultants".
undefined are not yet recruiting,
undefined are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Calgary Retina Consultants,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Calgary Retina Consultants, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 8 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".